Detalhe da pesquisa
1.
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
Oncologist
; 27(1): e76-e84, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305096
2.
EGFR mutation testing practice in advanced non-small cell lung cancer.
Lung
; 192(5): 759-63, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24964874
3.
A Single-Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC).
Diseases
; 12(5)2024 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785753
4.
Integrative physicians and an herbal cancer "cure".
Transl Lung Cancer Res
; 5(4): 443-5, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27652207